1- Lieberman, P. (2011). The basics of histamine biology. Ann. Allergy. Asthma Immunol. 106: 52 – 55.
2- Shahid, M., Tripathi, T., Sobia, F., Moin, S., Siddiqui, M. and Ali Khan, R. (2009). Histamine, histamine receptors, and their role in immunomodulation: An updated systematic review. O. I. Journal. 2: 9 – 41.
3- Haas, H. L., Sergeeva, O. A. and Selbach, O. (2008). Histamine in the Nervous System. Physiol. Rev. 88: 1183 – 1241.
4- Hau J, Van Hoosier Jr. GL. Handbook of laboratory animal science. Volume I, Essential Principles and practices. 2nd ed. Boca Raton: CRC Press; 2003.P. 112-315.
5- Flecknell P. Laboratory animal anaesthesia. 2nd ed. London: UK; Elsevier Academic Press; 1996.P. 7-73,159-237.
6- Raffa RB. Antihistamines as analgesics. J. Clin.Pharma.Therap. 2001; 26:81-85.
7- Ashmavi HA, ChambergoFS, Palmeira CCA, Posso IP. The effect of pyrilamine and cimetidine on mRNA C- Fos expression and nociceptive flinching behavior in rats. Anesth. Analg. 2003; 97: 541-546.
8- Zendehdel M, Torabi Z, Hassanpour S. Antinociceptive mechanisms of Bunium persicum essential oil in the mouse writhing test: role of opioidergic and histaminergic systems. Veterinarni Medicina.2015; 60:63-70.
9- Zendehdel M, Taati M, Amoozad M, Hamidi F. Antinociceptive effect of the aqueous extract obtained from Foeniculum vulgarein mice: the role of histamine H1and H2receptors. Iranian Journal of Veterinary Research.2012; 13:100-106.
10- Winter JC. Sedation and the Stimulus Properties of Antihistamines. Pharmacology Btochemtstry& Behawor.1985;22:15-17.
11- Hajighahramani, S. and Vesal, N. Evaluation of several drug combinations for intraperitoneal anaesthesia in adult male rats. Iranian Journal of Veterinary Research. 2007; 8 ; 106- 115.
12- Simpson DP. "Prolonged (12 hours) intravenous anesthesia in the rat". Lab. Anim. Sci. 1997; 47 (5): 519-523.
13- Clements JA, Nimmo WS. Pharmacokinetics and analgesic effects of ketamine in man. Br. J. Anaesth. 1981; 53: 27-30.
14- Gardner DJ., Davis J., Weina PJ., Theune B. Comparison of tribromoethanol, ketamine/acetylpromazine, telazol tm/xylazine, pentobarbital and methoxyflurane anesthesia in HSD: ICR Mice. Lab. Anim. Sci. 1995; 45(2): 199-204.
15- Hindmarch I., Shamsi Z. Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side-effects. Clinical and Experimental Allergy.1999; 29: 133-142.
16- Wixson S., White WJ. Hughes Jr. HC. Marshall WK., Lang CM. The effects of pentobarbital, fentanyl-droperidol, ketamine-xylazine and ketamine-diazepam on noxious stimulus perception in adult male rats. Lab. Anim. Sci. 1987; 37(6): 731-735.
17- Onodera K, Yamatodani A, Watanabe T, Wada H. Neuropharmacology of the histaminergic neuron system in the brain and its relationship with behavioral disorders. Prog Neurobiol. 1994; 42: 685-702.
18- Mobarakeh JI, Sakurada S, Katsuyama M, Kuramasu A, Lin ZY, et al. Role of histamine H1 receptor in pain perception: a study of the receptor gene knockout mice. Eur J Pharmacol. 2000; 391: 81-89.
19- Yanai K, Mobarakeh JI, Kuramasu A, Sakurada S. Role of histamine receptors in pain perception: a study using receptors gene knockout mice. Nippon Yakurigaku Zasshi. 2003; 122: 391-399.
20- Cannon KE, Hough LB. Inhibition of chemical and low- intensity mechanical nociception by activation of histamine H3 receptors. J Pain. 2005; 6: 193-200.
21- Ghelardini C, Galeotti N, Bartolini A. No develppment of tolerance to analgesia by repeated administration of H1 antagonists. Life Sci.1998; 63: 317-322.
22- Pual VN, Chopra K, Kulkarni SK. Histaminergic modulation of stress- induced analgesia and cognitive dysfunction. Methods Find Exp Clin Pharmacol. 2002; 24: 413-419.
23- Malec D. The influence of histamine receptor antagonists on antinociceptive action of narcotic analgesics. Pol J Pharmacol Pharm. 1987; 39 : 229- 235.
24- Galeotti N, Ghelardini C, Bartolini A. Antihistamine antinociception is mediated by Gi- protein activation. Neuroscience. 2002; 109: 811-818.
25- Nishibori M, Oishi R, Itoh Y, Saeki K. Morphine- induced changes in histamine dynamics in mouse brain. J Neurochem. 1985; 45: 719-724.
26- Suzuki T, Takamori K, Takahashi Y, Narita M, Misawa M, Onodera K. The differential effects of histamine receptor antagonists on morphine- and U- 50, 488 H- induced antinociceotion in the mouse. Life Sci. 1994; 54: 203-211.
27- Mobarakeh JI, Sakurada S, Hayashi T, Orito T, Okuyama K, Sakurada T, et al. Enhanced antinociception by intrathecally- administered morphine in histamine H1 receptor gene knockout mice. Neuropharmacology. 2002; 42: 1079-1088.
28- Farshchi A., Ghiasi G., Khatabi PM., Farzaee H and Niayesh A. Antinociceptive effect of promethazine in mice. Iranian journal of basic medical sciences.2009; (12) 4: 140-145.
29- Lamberti C., Bartolini A., Ghelardini C. and Malberg- Aiello P. Investigation into the role of histamine receptors in rodent antinociception. Pharmacol. Bioch. & Beh. 1996; (53) 3: 567-574.
30- Hedenqvist P.,Orr HE.,Roughan JV.,Antunes LM .,Flecknell PA. Anaesthesia with ketamine/medetomidine in the rabbit: influence of route of administration and the effect of combination with butorphanol. Vet. Anaesth. Analg. 2002; (29): 14-19.
31- Vogler GA. Anesthesia and analgesia. In: Suckow MA., Weisbroth SH.,Franklin CL. (Eds.) The laboratory rat. 2nd ed. Amsterdam: Elsevier Academic Press; 2006.P. 627-644.
32- Simons FER. Advances in H1-Antihistamines. The new england journal of medicine.2004;18:2203-2217.
33- Simons FER. H I-Receptor Antagonists Comparative Tolerability and Safety. Drug Safety.1994; 10 (5): 350-380.
34- Wisniewska AO., Olasinski J., Grajek S. Cardiovascular safety of antihistamines.Postepy dermatologii alergologii. 2014;3: 182-186.